NCT03191006

Brief Summary

Using double blind, randomized controlled design to investigate the short-term therapeutic effects of function of customized insoles on children with developmental delays

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 19, 2017

Completed
5 days until next milestone

Study Start

First participant enrolled

June 24, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
Last Updated

June 26, 2017

Status Verified

June 1, 2017

Enrollment Period

6 months

First QC Date

June 11, 2017

Last Update Submit

June 22, 2017

Conditions

Keywords

effectinsoleschildren

Outcome Measures

Primary Outcomes (1)

  • change from baseline functional performance (scores) at 12 weeks

    Pediatric Outcome Data Collection Instrument

    baseline and up to 12 weeks

Secondary Outcomes (3)

  • change from baseline physical function (time) at 12 weeks

    baseline and up to 12 weeks

  • change from baseline balance (scores) at 12 weeks

    baseline and up to 12 weeks

  • change from baseline quality of life at 12 weeks

    baseline and up to 12 weeks

Study Arms (2)

study group: MEI BIN insoles

ACTIVE COMPARATOR

Participants in the study group will be prescribed with a pair of customized insoles (MEI BIN) to keep the subtalar joint in neutral position, for 12 weeks.

Device: MEI BIN insoles

control group: without MEI BIN insoles

NO INTERVENTION

Participants in this control group will not receive a pair of customized insoles (MEI BIN) to keep the subtalar joint in neutral position, for 12 weeks.

Interventions

insoles

study group: MEI BIN insoles

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • developmental delays

You may not qualify if:

  • age less than 3 years old or older than 10 years old normal development

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shin Kong Wu Ho-Su Memorial Hospital

Taipei, 111-01, Taiwan

Location

MeSH Terms

Conditions

Learning Disabilities

Condition Hierarchy (Ancestors)

Communication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Officials

  • Ru-Lan Hsieh, MD

    Shin Kong Wu Ho-Su Memorial Hospital; Taipei Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ru-Lan Hsieh, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 11, 2017

First Posted

June 19, 2017

Study Start

June 24, 2017

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

June 26, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations